标题
The role of lipoprotein (a) in chronic kidney disease
作者
关键词
-
出版物
JOURNAL OF LIPID RESEARCH
Volume 59, Issue 4, Pages 577-585
出版商
American Society for Biochemistry & Molecular Biology (ASBMB)
发表日期
2018-01-30
DOI
10.1194/jlr.r083626
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
- (2017) Marc S. Sabatine et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease
- (2017) NEW ENGLAND JOURNAL OF MEDICINE
- Human Genetics and the Causal Role of Lipoprotein(a) for Various Diseases
- (2016) Florian Kronenberg CARDIOVASCULAR DRUGS AND THERAPY
- Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology
- (2016) Børge G. Nordestgaard et al. JOURNAL OF LIPID RESEARCH
- Phenotypic Characterization of Genetically Lowered Human Lipoprotein(a) Levels
- (2016) Connor A. Emdin et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences
- (2016) Nosratola D. Vaziri KIDNEY INTERNATIONAL
- Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials
- (2016) Nicholas J Viney et al. LANCET
- Effect of extended-release niacin on plasma lipoprotein(a) levels: A systematic review and meta-analysis of randomized placebo-controlled trials
- (2016) Amirhosssein Sahebkar et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Live donor study - implications of kidney donation on cardiovascular risk with a focus on lipid parameters including lipoprotein a
- (2016) Brian Doucet et al. NEPHROLOGY
- Lipoprotein(a) concentrations, apolipoprotein(a) isoforms and clinical endpoints in haemodialysis patients with type 2 diabetes mellitus: results from the 4D Study
- (2016) Barbara Kollerits et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Genome-wide study for circulating metabolites identifies 62 loci and reveals novel systemic effects of LPA
- (2016) Johannes Kettunen et al. Nature Communications
- Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials
- (2016) Lancet Diabetes & Endocrinology
- Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis
- (2016) Nathan R. Hill et al. PLoS One
- Mipomersen, an Antisense Oligonucleotide to Apolipoprotein B-100, Reduces Lipoprotein(a) in Various Populations With HypercholesterolemiaSignificance
- (2015) Raul D. Santos et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- ‘LDL-C’ = LDL-C + Lp(a)-C
- (2015) Calvin Yeang et al. CURRENT OPINION IN LIPIDOLOGY
- Lipoprotein(a) predicts a new onset of chronic kidney disease in people with Type 2 diabetes mellitus
- (2015) J.-S. Yun et al. DIABETIC MEDICINE
- Current therapies for lowering lipoprotein (a)
- (2015) Julian C. van Capelleveen et al. JOURNAL OF LIPID RESEARCH
- Lipoprotein (a): truly a direct prothrombotic factor in cardiovascular disease?
- (2015) Michael B. Boffa et al. JOURNAL OF LIPID RESEARCH
- Antisense inhibition of apolipoprotein (a) to lower plasma lipoprotein (a) levels in humans
- (2015) Mark J. Graham et al. JOURNAL OF LIPID RESEARCH
- Lipoprotein (a) in calcific aortic valve disease: from genomics to novel drug target for aortic stenosis
- (2015) George Thanassoulis JOURNAL OF LIPID RESEARCH
- Lipoprotein (a): impact by ethnicity and environmental and medical conditions
- (2015) Byambaa Enkhmaa et al. JOURNAL OF LIPID RESEARCH
- Cholesterol ester transfer protein inhibition by TA-8995 in patients with mild dyslipidaemia (TULIP): a randomised, double-blind, placebo-controlled phase 2 trial
- (2015) G Kees Hovingh et al. LANCET
- Antisense therapy targeting apolipoprotein(a): a randomised, double-blind, placebo-controlled phase 1 study
- (2015) Sotirios Tsimikas et al. LANCET
- Relation of Serum Lipids and Lipoproteins with Progression of CKD: The CRIC Study
- (2014) M. Rahman et al. Clinical Journal of the American Society of Nephrology
- Efficacy and safety of evolocumab (AMG 145), a fully human monoclonal antibody to PCSK9, in hyperlipidaemic patients on various background lipid therapies: pooled analysis of 1359 patients in four phase 2 trials
- (2014) E. A. Stein et al. EUROPEAN HEART JOURNAL
- Discrimination and Net Reclassification of Cardiovascular Risk With Lipoprotein(a)
- (2014) Peter Willeit et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Reduction in Lipoprotein(a) With PCSK9 Monoclonal Antibody Evolocumab (AMG 145)
- (2014) Frederick J. Raal et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effects of Extended-Release Niacin with Laropiprant in High-Risk Patients
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Plasma Lipoprotein(a) Levels Are Associated with Mild Renal Impairment in Type 2 Diabetics Independent of Albuminuria
- (2014) Jennie Lin et al. PLoS One
- AMG145, a Monoclonal Antibody Against Proprotein Convertase Subtilisin Kexin Type 9, Significantly Reduces Lipoprotein(a) in Hypercholesterolemic Patients Receiving Statin Therapy
- (2013) Nihar R. Desai et al. CIRCULATION
- Causes and consequences of lipoprotein(a) abnormalities in kidney disease
- (2013) Florian Kronenberg Clinical and Experimental Nephrology
- Lipoprotein(a): resurrected by genetics
- (2013) F. Kronenberg et al. JOURNAL OF INTERNAL MEDICINE
- Impact of lipoprotein(a) levels and apolipoprotein(a) isoform size on risk of coronary heart disease
- (2013) J. C. Hopewell et al. JOURNAL OF INTERNAL MEDICINE
- Relationship of Apolipoproteins A-1 and B, and Lipoprotein(a) to Cardiovascular Outcomes
- (2013) John J. Albers et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Notice
- (2012) Kidney International Supplements
- Antisense Oligonucleotide Lowers Plasma Levels of Apolipoprotein (a) and Lipoprotein (a) in Transgenic Mice
- (2011) Esther Merki et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
- (2011) Colin Baigent et al. LANCET
- Chronic kidney disease
- (2011) Andrew S Levey et al. LANCET
- Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Estimated Glomerular Filtration Rate and the Risk of Major Vascular Events and All-Cause Mortality: A Meta-Analysis
- (2011) Marion Mafham et al. PLoS One
- Lipoprotein(a) as a cardiovascular risk factor: current status
- (2010) Børge G. Nordestgaard et al. EUROPEAN HEART JOURNAL
- Apolipoprotein(a) Isoforms and the Risk of Vascular Disease
- (2010) Sebhat Erqou et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Safety of Anacetrapib in Patients with or at High Risk for Coronary Heart Disease
- (2010) Christopher P. Cannon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lipoprotein-A and carotid intima media thickness as cardiovascular risk factors in patients of chronic kidney disease
- (2010) Hari Krishan Aggarwal et al. RENAL FAILURE
- Genetically Elevated Lipoprotein(a) and Increased Risk of Myocardial Infarction
- (2009) Pia R. Kamstrup JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular Mortality
- (2009) JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Genetic Variants Associated with Lp(a) Lipoprotein Level and Coronary Disease
- (2009) Robert Clarke et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now